Affective Disorders Psychopharmacology
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 112
Special Issue Editor
2. Mental Health Department, The Ottawa Hospital, Ottawa, ON, Canada
3. King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Psychological Medicine, Centre for Affective Disorders, London, UK
Interests: affective disorders; psychopharmacology, neuroimaging
Special Issue Information
Dear Colleagues,
Affective disorders are complex and heterogeneous conditions with multiple aetiologies. Although current pharmacological treatments, largely discovered serendipitously, are effective, there is a pressing need to expand on current pharmacological strategies with interventions that target brain pathways based on more specific aetiological mechanisms.
This Special Issue, ‘Affective Disorders Psychopharmacology’, welcomes articles addressing current pharmacological approaches to treating affective disorders, and research work that explores limitations of existing strategies and/or offer perspectives related to novel pharmacological treatments.
The issue also welcomes articles reporting new strategies for detecting responsiveness to treatments and refractoriness in relation to the use of pharmacology in affective disorders by utilising a range of technologies including those that explore brain structure and function, putative peripheral markers of affective disorders, and genetic makeup/variation across the spectrum of affective disorders. We also encourage the submission of articles that compare pharmacological strategies with alternative treatment methods, particularly in relation to important topics such as treatment response, aetiological mechanisms, patients’ preferences, etc.
Dr. Danilo Arnone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psychopharmacology
- affective disorders
- mood disorders
- major depressive disorders
- bipolar affective disorders
